Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Stutterson Oct 21, 2022 10:15pm

734 Views

Post# 35040512

Davgro.

Explain to me why this company is such a good investment. How managememt exudes confidence. Explain to me why you defend a company that goes from $7.00 to .53 cents, has no real direction, is constantly delaYed in updates and has no news . A company which insiders dump shares at almost all tine lows. The people of this company are barely buying shares man. So Lets hear how I am, along with the rest of the market, wrong about the company?

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments